Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
113,323,168
-
Share change
-
+6,195,366
-
Total reported value
-
$9,190,397,578
-
Put/Call ratio
-
206%
-
Price per share
-
$81.10
-
Number of holders
-
672
-
Value change
-
+$458,525,808
-
Number of buys
-
240
-
Number of sells
-
386
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2025
As of 31 Mar 2025,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
672 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,323,168 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, JPMORGAN CHASE & CO, BNP PARIBAS FINANCIAL MARKETS, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
675
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.